Loading stock data…
AVAH
$6.59-0.15 (-2.23%)
Market ClosedLast close May 11
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Aveanna Healthcare Holdings Inc. in the Healthcare sector is trading at $6.59. The stock is currently 36% below its 52-week high of $10.32, remaining 15.9% below its 200-day moving average. Technical signals show neutral RSI of 56 and bullish MACD crossover, explaining why AVAH maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 56) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$6.59
Potential Downside
723.2%
Whystock Fair Value$-41.07
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.41B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
6.16
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.09
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-282.00%
Volume
Today's trading volume
938,642
Recent News
Unlocking Q1 Potential of Aveanna (AVAH): Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of Aveanna (AVAH) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Aveanna Healthcare Stock Is Up 23%. Here’s Why a Fund Still Sold $16 Million Worth
Aveanna Healthcare delivers home-based nursing and therapy services nationwide, with a focus on medically complex pediatric and adult care.
Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Pennant Group, Inc. (PNTG) Q1 Earnings and Revenues Surpass Estimates
The Pennant Group (PNTG) delivered earnings and revenue surprises of +4.92% and +2.42%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
A Look At Aveanna Healthcare Holdings (AVAH) Valuation After Recent Share Price Weakness
What recent performance says about Aveanna Healthcare Holdings Aveanna Healthcare Holdings (AVAH) has drawn fresh attention after a mixed run in its share performance, with a roughly 2% decline over the past day, a small gain over the past month, and a double digit drop in the past 3 months. In this context, the home care provider now carries a market value of about US$1.46b, supported by reported annual revenue of US$2.43b and net income of US$225.03m across its pediatric, adult, and medical...